blank
blank
On 24 February, in Brussels and online, EURORDIS will bring the rare disease community together for its fifteenth Black Pearl Awards ceremony, held in the lead‑up to Rare Disease Day.

EURORDIS Black Pearl Awards 2026: celebrating rare disease champions in Brussels and online

Black Pearl Awards

The EURORDIS Black Pearl Awards have been held annually since 2012 to recognise outstanding achievements by people living with a rare disease and those working alongside them — including patient advocates and organisations, policymakers, scientists, companies and others committed to improving lives. Since February 2023, the awards have been a fully hybrid event, with both in‑person participation in Brussels and an online platform.

For 2026, the ceremony will take place on Tuesday, 24 February at the Cardo Hotel, Brussels, with online participation available via EURORDIS’ interactive platform. The awards ceremony will also be translated into 61 languages.

2026 awardees highlighted

Among the 2026 awardees are: Jakub Dvořáček, recipient of the EURORDIS Policy Maker Award; Saventic Health, recipient of the EURORDIS Company Award for Health Technology; Dr Ágnes Cser, recipient of the EURORDIS Leadership Award; and Roche and King’s College London, as project leads of the AIMS-2-TRIALS consortium, recipients of the EURORDIS Company Award for Patient Engagement.

More information and registration details and agenda are available here.

News & Updates

You might also be interested in

webinar series ERDERA

Introductory webinar: Situating ethics in the research continuum

July 24 @ 3:00 pm - 4:00 pm
This webinar will present a theoretical framework for situating ethics across research activities. The framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.
State of the art rare disease country reports ERDERA

State of the art 2026 rare disease country report: Poland

This 2026 country report outlines the policy, research, care and support landscape for rare diseases in Poland.
NMG workshop 2026

ERDERA National Mirror Groups workshop: Creating, evolving and utilising national registries to advance rare disease research

Held in Riga on 9–10 June, the workshop brought National Mirror Group experts, researchers, clinicians and policymakers together to exchange practical lessons on how national rare disease registries can better support research and alignment across countries.
2

ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases

ERDERA (the European Rare Diseases Research Alliance) has opened its Clinical Trial Call to support multinational early-phase clinical trials in rare diseases. The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.

ERDERA's

search form